Evaluating the cytotoxicity of ionic liquids using human cell line HeLa

Human and Experimental Toxicology

Volumn 23, Issue 11, 2004, Pages 513-517

  Stepnowski, Piotr ^a   Skladanowski A C ^b   Ludwiczak, A ^b   Laczynska E ^a  

^a UNIVERSITY OF GDA SK   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Cytotoxicity; HeLa cell line; Ionic liquids; Prospective risk assessment

Indexed keywords

1 N BUTYL 3 ETHYLIMIDAZOLIUM CHLORIDE; 1 N BUTYL 3 METHYLIMIDAZOLIUM; 1 N BUTYL 3 METHYLIMIDAZOLIUM CHLORIDE; 1 N BUTYL 3 METHYLIMIDAZOLIUM HEXAFLUOROPHOSPHATE; 1 N BUTYL 3 METHYLIMIDAZOLIUM TETRAFLUOROBORATE; 1 N DECYL 3 METHYLIMIDAZOLIUM CHLORIDE; 1 N HEXYL 3 METHYLIMIDAZOLIUM CHLORIDE; ANION; BORIC ACID; DICHLOROMETHANE; IMIDAZOLE DERIVATIVE; IMIDAZOLIUM IONIC LIQUID; METHYL GROUP; ORGANIC SOLVENT; TETRAFLUOROBORATE; TOLUENE; UNCLASSIFIED DRUG; XYLENE;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ECOTOXICITY; HELA CELL; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; PRIORITY JOURNAL; TOXICITY; TUMOR CELL LINE;

BORATES; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HUMANS; HYDROPHOBICITY; IMIDAZOLES; IONS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOLVENTS; TOXICITY TESTS;

EID: 10344227672     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327104ht480oa     Document Type: Article

References (13)

1. Welton T. Room-temperature ionic liquids. Solvents for synthesis and catalysis. Chem Rev 1999; 99: 2071-83.
2. Holbrey JD, Seddon KR. Clean Prod Process 1999; 1: 223-37.
3. Wasserscheid P, Keim W. Ionische Flüssigkeiten - neue 'Lösungen' für die Übergangsmetallkatalyse. Angew Chem 2000; 112: 3926-45.
4. Sheldon R. Catalytic reactions in ionic liquids. Chem Commun 2001: 2399-2407.
5. Dupont J, de Souza RF, Suarez PAZ. Ionic liquid (molten salt) phase organometallic catalysis. Chem Rev 2002; 102: 3667-92.
6. Gordon CM. New developments in catalysis using ionic liquids, Appl. Catal A 2001; 222: 101-17.
7. Jastorff B, Störmann R, Ranke J, Mölter K, Stock F, Oberheitmann B, Hoffman W, Hoffmann J, Nüchter M, Ondruschka B, Filser J. How hazardous are ionic liquids? Structure-activity relationships and biological testing as important elements for sustainability evaluation. Green Chem 2003; 5: 136-42.
8. Ranke J, Mölter K, Stock F, Bottin-Weber U, Poczobutt J, Hoffmann J, Ondruschka B, Filser J, Jastorff B. Biological effects of imidazolium ionic liquids with varying chain lengths in acute Vibrio fischeri and WST-1 cell viability assays. Ecotox Environ Safety 2003 (in press, available online).
9. Stepnowski P, Storoniak P. Prospective environmental assessment of imidazolium ionic liquids: lipophilicity and metabolic routes. 9th FECS Conference on Chemistry and the Environment, Bordeaux, France, 2004.
10. Skladanowski AC, Stepnowski P, Kleszczyński K, Dmochowska B. AMP deaminase in vitro inhibition by synthetic nitro- and polycyclic musks, imidazolium ionic liquids and N-glucopyranosyl ammonium salts as a potential molecular method for prospective and retrospective risk assessment of xenobiotics. Environ Toxicol Pharmacol 2004; 28: 396-404.
11. Swatloski RP, Holbrey JD, Rogers RD. Ionic liquids are not always green: hydrolysis of 1-butyl-3-methylimidazolium hexafluorophosphate. Green Chem 2003; 5: 361-63.
12. Hansh C, Leo A. Exploring QSAR. ACS Professional Reference Book. ACS: Washington, DC, 1995.
13. Malich G, Markovic B, Winder C. The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicol 1997; 124: 179-92.